Skip to main content

Imunon, Inc.

IMNN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000749647

In the last 90 days, Imunon, Inc. insiders filed 0 open-market purchases and 5 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $506.1K in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Imunon, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of IMNN: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders2617−9
SharesConverted for a 1-for-13 split170.0K157.4K−12.6K (−7.4%)
Value$1.76M$879.0K−$882.5K (−50.1%)

New holders (2)

Institutions that held Imunon, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to IMNN in Q3 2025
InstitutionSharesValue% of portfolio
DRW Securities, LLC55,027$282.3K0.01%
Steigerwald, Gordon & Koch Inc.1$50.00%

Sold out (11)

Institutions that held Imunon, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of IMNN in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Sabby Management, LLC900,000$720.0K
Renaissance Technologies LLC638,000$510.4K
Virtu Financial LLC41,073$33.0K
Two Sigma Investments, LP29,578$23.7K
XTX Topco Ltd29,409$23.5K
Northern Trust Corp21,640$17.3K
State Street Corp21,303$17.0K
Baader Bank INC21,583$10.7K
Two Sigma Securities, LLC12,916$10.3K
FMR LLC501$401
Advisor Group Holdings, Inc.14$11